• Lysergic Acid Diethylamide, Urine
  • Fungitell® ß-D Glucan, CSF
  • Hepatitis D Virus (HDV) RNA, Molecular Method
  • Mumps Virus Antibody, IgG
  • Vancomycin, Peak, Serum
  • Theophylline, Urine
  • Hepatitis B Surface Antibody, Qualitative
  • Integrin Subunit Beta 3 (ITGB3) Gene Mutation Analysis
  • Manganese, Serum
  • Treponema pallidum Antibody by TP-PA, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
Medical Test

Clinical Utility
Access to Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS is restricted.